Significant tumor responses were observed at 1 mg/kg LNP-CTNNB1 dosage as noted via H&E, IHC for Myc-tag and GS/Ki67, and magnetic resonance imaging (MRI) (Fig. 1g; Supplementary Fig. 3a–d). This evidence concerns the gene MYC and neoplasm.